EnnovaBio is Drug Discovery in China that focus on medical practitioners business. Founded in 2016. They cover business area such as developer, researcher, immunotherapy pharmaceutical, prevalent autoimmune disease, China, target therapeutic drug, various autoimmune and inflammatory disease, innovative and sophisticated immunotherapy product, patient, medical practitioner.
2016
( 8 years old in 2024 )
Medical Practitioners
-
4F, No. 2
Lane 720, Cailun Road, Pudong New District
Shanghai, 201203
China
Private
developerresearcherimmunotherapy pharmaceuticalprevalent autoimmune diseaseChinatarget therapeutic drugvarious autoimmune and inflammatory diseaseinnovative and sophisticated immunotherapy productpatientmedical practitioner
* We use standard office opening hours in near EnnovaBio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EnnovaBio is Drug Discovery business from China that founded in 2016 (8 years old in 2024), EnnovaBio business is focusing on Medical Practitioners.
EnnovaBio headquarter office and corporate office address is located in 4F, No. 2 Lane 720, Cailun Road, Pudong New District Shanghai, 201203 China.
EnnovaBio was founded in China.
In 2024, EnnovaBio is currently focus on medical practitioners sector.
Above is snippet of Google Trends for "medical practitioners" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EnnovaBio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
